Headquarter Moves to Lund to Accelerate Development
Press ReleasesAfter presenting encouraging preclinical results in January — demonstrating highly valuable clinical benefits — Sangair AB now takes the next…
Read ArticlePress Releases
Media
New article with positive results published
News, Press ReleasesNew article with positive results published by the team behind Sangair! Sepsis carries a high mortality rate, and current treatments…
Read ArticleWorld Sepsis Day 2025
Press ReleasesOn September 13th, the global spotlight is on sepsis – an acute, life-threatening condition affecting over 47 -50 million people…
Read ArticleClear effect in pre-clinical study
Press ReleasesSangair team can share some exciting news. Our ongoing pre-clinical study shows a clear effect. SangAspet™ lowers the number of…
Read ArticleSangair patent is approved in Canada
Press ReleasesThe intellectual property family has expanded with an approved patent application in Canada, pertaining to ozonation of blood, and more…
Read Article